Literature DB >> 19043416

Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness.

Chantal Lagresle-Peyrou1, Emmanuelle M Six, Capucine Picard, Frédéric Rieux-Laucat, Vincent Michel, Andrea Ditadi, Corinne Demerens-de Chappedelaine, Estelle Morillon, Françoise Valensi, Karen L Simon-Stoos, James C Mullikin, Lenora M Noroski, Céline Besse, Nicolas M Wulffraat, Alina Ferster, Manuel M Abecasis, Fabien Calvo, Christine Petit, Fabio Candotti, Laurent Abel, Alain Fischer, Marina Cavazzana-Calvo.   

Abstract

Reticular dysgenesis is an autosomal recessive form of human severe combined immunodeficiency characterized by an early differentiation arrest in the myeloid lineage and impaired lymphoid maturation. In addition, affected newborns have bilateral sensorineural deafness. Here we identify biallelic mutations in AK2 (adenylate kinase 2) in seven individuals affected with reticular dysgenesis. These mutations result in absent or strongly decreased protein expression. We then demonstrate that restoration of AK2 expression in the bone marrow cells of individuals with reticular dysgenesis overcomes the neutrophil differentiation arrest, underlining its specific requirement in the development of a restricted set of hematopoietic lineages. Last, we establish that AK2 is specifically expressed in the stria vascularis region of the inner ear, which provides an explanation of the sensorineural deafness in these individuals. These results identify a previously unknown mechanism involved in regulation of hematopoietic cell differentiation and in one of the most severe human immunodeficiency syndromes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19043416      PMCID: PMC2612090          DOI: 10.1038/ng.278

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  26 in total

1.  Different mitochondrial intermembrane space proteins are released during apoptosis in a manner that is coordinately initiated but can vary in duration.

Authors:  Cristina Muñoz-Pinedo; Ana Guío-Carrión; Joshua C Goldstein; Patrick Fitzgerald; Donald D Newmeyer; Douglas R Green
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

2.  Successful cord blood transplantation in a premature and dysmature neonate of 1700 g with reticular dysgenesis.

Authors:  L L Reubsaet; J J Boelens; C Rademaker; J Smal; N M Wulffraat
Journal:  Bone Marrow Transplant       Date:  2007-01-29       Impact factor: 5.483

3.  Successful haploidentical bone marrow transplantation in a patient with reticular dysgenesis: three-year follow-up.

Authors:  Meredith Lee Heltzer; Michele Paessler; Leslie Raffini; Nancy Bunin; Elena Elizabeth Perez
Journal:  J Allergy Clin Immunol       Date:  2007-09-12       Impact factor: 10.793

4.  HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease).

Authors:  Christoph Klein; Magda Grudzien; Giridharan Appaswamy; Manuela Germeshausen; Inga Sandrock; Alejandro A Schäffer; Chozhavendan Rathinam; Kaan Boztug; Beate Schwinzer; Nima Rezaei; Georg Bohn; Malin Melin; Göran Carlsson; Bengt Fadeel; Niklas Dahl; Jan Palmblad; Jan-Inge Henter; Cornelia Zeidler; Bodo Grimbacher; Karl Welte
Journal:  Nat Genet       Date:  2006-12-24       Impact factor: 38.330

5.  Connexin30 deficiency causes instrastrial fluid-blood barrier disruption within the cochlear stria vascularis.

Authors:  Martine Cohen-Salmon; Béatrice Regnault; Nadège Cayet; Dorothée Caille; Karine Demuth; Jean-Pierre Hardelin; Nathalie Janel; Paolo Meda; Christine Petit
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-30       Impact factor: 11.205

Review 6.  Dynamics of nucleotide metabolism as a supporter of life phenomena.

Authors:  Takafumi Noma
Journal:  J Med Invest       Date:  2005-08

7.  Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons.

Authors:  Jyh-Rong Chao; Evan Parganas; Kelli Boyd; Cheol Yi Hong; Joseph T Opferman; James N Ihle
Journal:  Nature       Date:  2008-02-20       Impact factor: 49.962

8.  AK2 activates a novel apoptotic pathway through formation of a complex with FADD and caspase-10.

Authors:  Ho-June Lee; Jong-Ok Pyo; Yumin Oh; Hyo-Jin Kim; Se-hoon Hong; Young-Jun Jeon; Hyunjoo Kim; Dong-Hyung Cho; Ha-Na Woo; Sungmin Song; Jung-Hyun Nam; Hyo Joon Kim; Key-Sun Kim; Yong-Keun Jung
Journal:  Nat Cell Biol       Date:  2007-10-21       Impact factor: 28.824

9.  A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.

Authors:  Ian M Morison; Elisabeth M Cramer Bordé; Emma J Cheesman; Pak Leng Cheong; Andrew J Holyoake; Serge Fichelson; Robert J Weeks; Alexandra Lo; Stefan M K Davies; Sigurd M Wilbanks; Robert D Fagerlund; Mathew W Ludgate; Fernanda M da Silva Tatley; Melanie S A Coker; Nicholas A Bockett; Gillian Hughes; Diana A Pippig; Mark P Smith; Claude Capron; Elizabeth C Ledgerwood
Journal:  Nat Genet       Date:  2008-03-16       Impact factor: 38.330

10.  A human postnatal lymphoid progenitor capable of circulating and seeding the thymus.

Authors:  Emmanuelle M Six; Delphine Bonhomme; Marta Monteiro; Kheira Beldjord; Monika Jurkowska; Corinne Cordier-Garcia; Alexandrine Garrigue; Liliane Dal Cortivo; Benedita Rocha; Alain Fischer; Marina Cavazzana-Calvo; Isabelle André-Schmutz
Journal:  J Exp Med       Date:  2007-12-10       Impact factor: 14.307

View more
  69 in total

1.  Molecular diagnosis of severe combined immunodeficiency--identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children.

Authors:  Pamela P W Lee; Koon-Wing Chan; Tong-Xin Chen; Li-Ping Jiang; Xiao-Chuan Wang; Hua-Song Zeng; Xiang-Yuan Chen; Woei-Kang Liew; Jing Chen; Kit-Man Chu; Lee-Lee Chan; Lynette Shek; Anselm C W Lee; Hsin-Hui Yu; Qiang Li; Chen-Guang Xu; Geraldine Sultan-Ugdoracion; Zarina Abdul Latiff; Amir Hamzah Abdul Latiff; Orathai Jirapongsananuruk; Marco H K Ho; Tsz-Leung Lee; Xi-Qiang Yang; Yu-Lung Lau
Journal:  J Clin Immunol       Date:  2010-12-24       Impact factor: 8.317

2.  Adenylate kinase 2 links mitochondrial energy metabolism to the induction of the unfolded protein response.

Authors:  Alison Burkart; Xiarong Shi; My Chouinard; Silvia Corvera
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

Review 3.  Primary antibody deficiencies.

Authors:  Anne Durandy; Sven Kracker; Alain Fischer
Journal:  Nat Rev Immunol       Date:  2013-06-14       Impact factor: 53.106

4.  Molecular basis of congenital neutropenia.

Authors:  Christoph Klein
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

5.  Simple oxygraphic analysis for the presence of adenylate kinase 1 and 2 in normal and tumor cells.

Authors:  Aleksandr Klepinin; Lyudmila Ounpuu; Rita Guzun; Vladimir Chekulayev; Natalja Timohhina; Kersti Tepp; Igor Shevchuk; Uwe Schlattner; Tuuli Kaambre
Journal:  J Bioenerg Biomembr       Date:  2016-11-17       Impact factor: 2.945

6.  Growth factor independence 1 (Gfi1) regulates cell-fate decision of a bipotential granulocytic-monocytic precursor defined by expression of Gfi1 and CD48.

Authors:  Lothar Vassen; Ulrich Dührsen; Christian Kosan; Hui Zeng; Tarik Möröy
Journal:  Am J Blood Res       Date:  2012-11-25

7.  Limb girdle myasthenia with digenic RAPSN and a novel disease gene AK9 mutations.

Authors:  Ching-Wan Lam; Ka-Sing Wong; Ho-Wan Leung; Chun-Yiu Law
Journal:  Eur J Hum Genet       Date:  2016-12-14       Impact factor: 4.246

Review 8.  Genetic insights into congenital neutropenia.

Authors:  Christoph Klein; Karl Welte
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

Review 9.  Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing.

Authors:  Petras Dzeja; Andre Terzic
Journal:  Int J Mol Sci       Date:  2009-04-17       Impact factor: 6.208

Review 10.  Genetics of SCID.

Authors:  Fausto Cossu
Journal:  Ital J Pediatr       Date:  2010-11-15       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.